Period of time： 2012年2期
Publisher： Adis International
Founded in： 1994
Total resources： 114
ISSN： 1173-8804
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
BioDrugs,volume 20,issue 2
Menu
Orphan Drug Designation and Pharmacogenomics: Options and Opportunities
By Maher Paul D.,Haffner Marlene in (2006)
BioDrugs,volume 20,issue 2 , Vol. 20, Iss. 2, 2006-01 , pp.
Access to resources
Recommend
Immunostimulants Revisited: Focus on the Pharmacology of Ribomunyl®
By Portalès Pierre,Clot Jacques in (2006)
BioDrugs,volume 20,issue 2 , Vol. 20, Iss. 2, 2006-01 , pp.Efficacy of Alemtuzumab in Organ Transplantation: Current Clinical Status
By Ciancio Gaetano,Burke George W.,Warque Maria E.,Miller Joshua in (2006)
BioDrugs,volume 20,issue 2 , Vol. 20, Iss. 2, 2006-01 , pp.Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis
By Numerof Robert P. in (2006)
BioDrugs,volume 20,issue 2 , Vol. 20, Iss. 2, 2006-01 , pp.Spotlight on Gemtuzumab Ozogamicin in Acute Myeloid Leukaemia
By Fenton Caroline,Perry Caroline M. in (2006)
BioDrugs,volume 20,issue 2 , Vol. 20, Iss. 2, 2006-01 , pp.